Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease

NeuroToxicology

Volumn 39, Issue , 2013, Pages 57-64

  Khurana, Navneet ^a   Gajbhiye, Asmita ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Dopamine; Histopathological evaluation; Lipid peroxidation; Parkinson's disease; Rotenone; Sida cordifolia

Indexed keywords

CATALASE; CHLOROFORM; DOPAMINE; GLUTATHIONE; HEXANE; NORADRENALIN; SELEGILINE; SEROTONIN; SIDA CORDIFOLIA EXTRACT; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BALANCE IMPAIRMENT; BEHAVIOR CHANGE; BRAIN CORTEX; CATALEPSY; CEREBELLUM; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG EFFECT; DRUG MECHANISM; HISTOPATHOLOGY; MALE; MALVACEAE; MESENCEPHALON; NEUROPROTECTION; NONHUMAN; NORADRENALIN BRAIN LEVEL; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REARING; SEROTONIN BRAIN LEVEL; SIDA CORDIFOLIA;

5-HT; AESC; AFSC; AQUEOUS EXTRACT OF SIDA CORDIFOLIA; AQUEOUS FRACTION OF EXTRACT; CAT; CATALASE; CFSC; CHLOROFORM SOLUBLE FRACTION OF EXTRACT; DA; DOPAMINE; GLUTATHIONE; GSH; HEXANE SOLUBLE FRACTION OF EXTRACT; HFSC; HISTOPATHOLOGICAL EVALUATION; LIPID PEROXIDATION; NE; NOREPINEPHRINE; PARKINSON'S DISEASE; PD; REACTIVE OXYGEN SPECIES; ROS; ROTENONE; SAG; SEROTONIN; SIDA CORDIFOLIA; SUPEROXIDE ANION GENERATION; TBARS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALS; BRAIN; CATALEPSY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; INSECTICIDES; MALE; MALVACEAE; NEUROTRANSMITTER AGENTS; OXIDATIVE STRESS; PARKINSON DISEASE; PHYTOTHERAPY; PLANT EXTRACTS; POSTURAL BALANCE; RATS; RATS, SPRAGUE-DAWLEY; ROTENONE; SENSATION DISORDERS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84883639808     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2013.08.005     Document Type: Article

References (43)

1. Aebi H.Catalase Methods of Enzymatic Analysis 1974, 673-685. Chemic Academic Press, NY. 2nd ed. H.U. Bergmeyer (Ed.).
2. Alam M., Mayarhofer A., Schmidt W.J. The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by l-DOPA. Behav Brain Res 2004, 151:117-124.
3. Al-Quraishy S., Dkhil M.A., Moneim A.E.A. Protective effects of Portulaca oleracea against rotenone mediated depletion of glutathione in the striatum of rats as an animal model of Parkinson's disease. Pest Biochem Physiol 2012, 103:108-114.
4. Auddy B., Ferreira M., Blasina F., Lafon L., Arredondo F., Dajas F., et al. Screening of antioxidant activity of three Indian medicinal plants, traditionally used for the management of neurodegenerative diseases. J Ethnopharmacol 2003, 84:131-138.
5. Betarbet R., Sherer T.B., Mackenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000, 3:1301-1306.
6. Beutler R.G., Duron O., Kelly B. Reduced glutathione estimation. J Lab Clin Med 1963, 61:82.
7. Cannon J.R., Tapias V., Na H.M., Honick A.S., Drolet R.E., Greenamyre J.T. A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis 2009, 34:279-290.
8. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979, 3:527-605.
9. Costall B., Naylor R.J. On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity. Psychopharmacologia 1974, 34:233-241.
10. Dexter D.T., Carter C.J., Wells F.R., Javoy-Agid F., Agid Y., Lees A., et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1989, 52(2):381-389.
11. Dexter D.T., Holley A.E., Flitter W.D., Slater T.F., Wells F.R., Daniel S.E., et al. Increased level of lipid hydroperoxides in the Parkinsonian substantia nigra: an HPLC and ESR study. Mov Disord 1994, 9(1):92-97.
12. Douna H., Bavelaar B.M., Pellikaan H., Olivier B., Pieters T. Neuroprotection in Parkinson's disease: a systematic review of the preclinical data. Open Pharmacol J 2012, 6:12-26.
13. Girish C., Muralidhara Propensity of Selaginella delicatula aqueous extract to offset rotenone-induced oxidative dysfunctions and neurotoxicity in Drosophila melanogaster: implications for Parkinson's disease. Neurotoxicology 2012, 33:444-456.
14. Hastings T.G., Lewis D.A., Zigmond M.J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci U S A 1996, 93:1956-1961.
15. Hosamani R., Muralidhara Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster. Neurotoxicology 2009, 30:977-985.
16. Humanson G.L. Animal tissue technique 1962, 3-126. Freeman WH, San Francisco, DOI:http://dx.doi.org/10.5962/bhl.title.5890.
17. Jenner P., Olanow C.W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 1996, 47:161-170.
18. Lowry A.H., Rosenbrough M.J., Farr A.L., Randall R.J. Protein measurement with Folin-phenol reagent. J Biol Chem 1951, 193:265-275.
19. Madepalli K.L., Trichur R.R. An isocratic assay for norepinephrine, dopamine, and 5-hydroxytryptamine using their native fluorescence by high-performance liquid chromatography with fluorescence detection in discrete brain areas of rat. Anal Biochem 1997, 246:166-170.
20. Munhall A.C., Johnson S.W. Dopamine-mediated actions of ephedrine in the rat substantia nigra. Brain Res 2006, 1069:96-103.
21. Nagashayana N., Sankarankutty P., Nampoothiri M.R., Mohan P.K., Mohanakumar K.P. Association of l-dopa with recovery following ayurveda medication in Parkinson's disease. J Neurol Sci 2000, 176:124-127.
22. Nehru B., Verma R., Khanna P., Sharma S.K. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine. Brain Res 2008, 1201:122-127.
23. Ohkawa H., Ohishi N., Yagi N. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Ann Biochem 1979, 5:351-358.
24. Pattar P.V., Jayaraj M. Pharmacognostic and phytochemical investigation of Sida cordifolia l. - A threatened medicinal herb. Int J Pharm Pharm Sci 2012, 4(1):114-117.
25. Puri H.S. 'Rasayana' - ayurvedic herbs for longevity and rejuvenation 2003, 64-70. Taylor and Francis, London.
26. Rani N.U., Ananthi T. The antioxidant activity of ferulic acid on MPTP induced Parkinson's disease in mice. Asian J Microbiol Biotechnol Environ Sci 2011, 13(4):677-683.
27. Rastogi R.P., Malhotra B.N. Compendium of indian medical plants 1985, 4:674.
28. Sanchez-Reus M.I., Gomez del Rio M.A., Iglesias I., Elorza M., Slowing K., Bened J. Standardized Hypericum perforatum reduces oxidative stress and increases gene expression of antioxidant enzymes on rotenone-exposed rats. Neuropharmacology 2007, 52:606-616.
29. Saravanan K.S., Sindhu K.M., Senthilkumar K.S., Mohanakumar K.P. l-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats. Neurochem Int 2006, 49:28-40.
30. Scott B.C., Butler J., Halliwell B., Aruoma O.I. Evaluation of the antioxidant actions of ferulic acid and catechins. Free Radic Res Commun 1993, 19:241-253.
31. Sharma N., Bafna P. Effect of Cynodon dactylon on rotenone induced Parkinson's disease. Orient Pharm Exp Med 2012, 12(3):167-175.
32. Sherer T.B., Betarbet R., Testa C.M., Seo B.B., Richardson J.R., Kim J.H., et al. Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 2003, 23(34):10756-10764.
33. Sherer T.B., Richardson J.R., Testa C.M., Seo B.B., Panov A.V., Yagi T., et al. Mechanism of toxicity of pesticides acting at complex 1: relevance to environmental etiologies of Parkinson's disease. J Neurochem 2007, 100(6):1469-1479.
34. Singh A.P., Singh M., Balakumar P. Effect of mast cell stabilizers in hyperhomocysteinemia-induced cardiac hypertrophy in rats. J Cardiovasc Pharmacol 2008, 51(6):596-604.
35. Songa J.X., Szea S.C.W., Ngd T.B., Leeb C.K.F., Leungc G.P.H., Shawe P.C., et al. Anti-parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models?. J Ethnopharmacol 2012, 139:698-711.
36. Swarnkar S., Singh S., Sharma S., Mathur R., Patro I.K., Nath C. Rotenone induced neurotoxicity in rat brain areas: a histopathological study. Neurosci Lett 2011, 501:123-127.
37. Swathy S.S., Panicker S., Nithya R.S., Anuja M.M., Rejitha S., Indira M. Antiperoxidative and antiinflammatory effect of Sida cordifolia Linn. on quinolinic acid induced neurotoxicity. Neurochem Res 2010, 35(9):1361-1367.
38. Trushina E., Mcmurray C.T. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neurosci 2007, 145:1233-1248.
39. Verma R., Nehru B. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease. Neurochem Int 2009, 55:369-375.
40. Wang H.D., Pagano P.J., Du Y., Cayatte A.J., Quinn M.T., Brecher P., Cohen R.A. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 1998, 82:810-818.
41. Yong R., Liu R.W., Jiang H., Jiang Q., Feng J. Selective vulnerability of dopaminergic neurons to microtubule depolymerization. J Biol Chem 2005, 280(40):34105-34112.
42. Zhang H., Maka S., Cui W., Li W., Han R., Hua S., et al. Tacrine(2)-ferulic acid, a novel multifunctional dimer, attenuates 6-hydroxydopamine-induced apoptosis in PC12 cells by activating Akt pathway. Neurochem Int 2011, 59:981-988.
43. 2 release at mitochondria complex-1. J Biol Chem 2005, 280(16):15587-15594.